Spread the loveIn a groundbreaking study, researchers from Sweden have unveiled an artificial intelligence (AI) system capable of predicting the risk of melanoma years before it manifests. This ...
-- PanGIA Analysis System, a novel machine learning platform for non-invasive diagnosis of oral cancer through an oral sample -- PanGIA Analysis System, a novel machine learning platform for ...
PanGIA Biotech, Inc. ("PanGIA") announced a peer-reviewed clinical study published in Diagnostics, "Urine-Based Machine ...
TOBY, Inc., a biotechnology company developing non-invasive cancer screening technologies, today announced that the U.S. Food ...
Harbinger Health, a Cambridge biotech spun out of Flagship, says it has locked in $100 million in new financing as it races ...
Former Castle Biosciences SVP brings proven diagnostic commercialization and reimbursement leadership to NovaScan’s ...
Irvine-based Helio Genomics announces partnership with Quest Diagnostics to distribute its liver cancer detection test ...
A machine learning model that analyzes patient demographics, electronic health record data, and routine blood test results predicted a patient's risk of hepatocellular carcinoma (HCC), the most common ...
{image id=1352663 align=left size=large byline=true caption="The Massachusetts General Hospital, home to Mass Eye and Ear and part of the Mass General Brigham system ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results